10:00 AM EST - Tekmira Pharmaceuticals Corporation : announced today that promising preclinical data from its collaboration with the National Cancer Institute has been published in Oncogene, one of the world's leading cancer journals. Tekmira Pharmaceuticals Corporation
shares T.TKM are trading up $0.05 at $2.65.
